Follow our financial story as we change the future of medicine.
On this page you can find financial reports, news and other information on CELLINK. Subscribe to our page to get all the latest updates.
Latest press releasesMore
May 14, 2020CELLINK announces collaboration with AstraZeneca to utilize CELLINKs’ 3D-bioprinting technology for liver organoid culture
April 18, 2020CELLINK's founders informs about executing a call option
March 31, 2020CELLINK AB (publ) receives an order of SEK 5,200,000 from the National Board of Health and Welfare in Sweden
March 25, 2020CELLINK launches a real-time qPCR instrument
March 4, 2020CELLINK has received a grant to develop a new organ-like in vitro model that can be used in drug development and testing for renal diseases.
February 3, 2020CELLINK announces extension of collaboration with AstraZeneca to use CELLINKs’ 3D-bioprinting and associated technology for drug discovery
January 9, 2020CELLINK is carrying out stock split (4:1)
December 23, 2019CELLINK signs agreement to expand its production area
November 14, 2019Annual Report 2018/2019
November 4, 2019Bioprinting advanced skin architecture complete with blood vessels using CELLINK technology
October 22, 2019Karolinska Institute study shows CELLINK’s I-DOT liquid-handling system can enable genetic cancer diagnostic research
October 14, 2019CELLINK is awarded Entrepreneur of the Year in Sweden 2019
October 2, 2019CELLINK and partner Prellis Biologics awarded Merck Innovation Award for cutting-edge technology designed to empower pharmaceutical research.
October 1, 2019CELLINK granted design patent for BIO X
September 3, 2019CELLINK announces a new product designed to be the most flexible six-printhead bioprinting platform on the market.
July 9, 2020Interim report March – May 2020
October 22, 2020Interim report June – August 2020
February 25, 2021Year-end report September - December (Q1-Q5) 2019/2020
March 17, 2021Annual report 2019/2020